9. Egger J, Wilson J 1983 Mitochondrial inheritance in a mitochondridly mediated disease. N Engl J We have studied the pulmonary function of these models induced by injecting rats subcutaneously with reserpine (RES, 0.5 mg/kg/day), isoproterenol (ISO, 25 mg/kg/day), or saline (Con, 1.0 ml/kg/day) for 6 days. Plethysmorgraphic measurements were made for functional residual capacity (FRC), airways resistance (R.,), specific airways conductance (&.,), phase difference between air flow rate and mean alveolar pressure (PD), frequency of breathing (f), and tidal volume (VT) of the anesthetized rats. In the RES and I S 0 rats, the FRC, R. , and f were not different from Con values. The PD was greater and the V, was less than Con values (p < 0.05).
The results of both studies indicate uneven ventilation (increased PD) and pcnddujl (decreased VT) consistent with maldistribution of resistance and/or compliances of the peripheral airways and/ or alveolar compartments. These physiologic effects can be related to the morphologic changes reported for the airways of rats under chronic adrenergic stimulation (ISO) and expected for rats under chronic catecholamines depletion (RES). Since peripheral airways involvement is usually the earliest pulmonary lesion found in CF, these studies indicate that the RES and I S 0 models may be representative of the early pulmonary involvement of CF.
Abbreviations CF, cystic fibrosis RES, reserpine ISO, isoproterenol sulfate Con, saline CF is a genetic exocrinopathy which affects 1: 1600 live births among Caucasians. Patients with CF presumably have morphologically normal lungs at birth, as seen in infants dying of meconium ileus (2) . The earliest pulmonary lesions in CF are dilatation and hypertrophy of bronchial glands and goblet cells, as well as metaplasia of the bronchiolar epithelium followed shortly by mucous plugging of peripheral airways (17) . Subsequently, a vicious cycle of obstruction, chronic infection, and more tissue damage ensues.
The earliest manifestation of pulmonary dysfunction in CF is an abnormality in the distribution of ventilation resulting in increased alveolar-arterial oxygen differences. This may occur before any detectable changes in flow rates or lung volumes. Tests of peripheral airways function, such as frequency dependence of dynamic compliance or flow rates at low lung volumes, may also show abnormalities in CF patients in whom more standard ventilatory measurements are still normal. These observations are consistent with the concept that the initial pulmonary lesion is in the peripheral airways (17) .
Laboratory research of this disease has been hampered by the lack of a naturally occumng equivalent in animals (5). While no genetic animal model for CF has been found, two methods of chemical induction of pathophysiologic and morphologic changes in rats resembling the exocrinopathies of CF have been developed by chronic administration of reserpine (7, 8) and isoproterenol (6, 14) .
Reserpine is a catecholamine depleter which lowers noradrenaline content of salivary glands and other tissues (3). The reserpine model has been used in showing that alterations of sympathetic neurotransmitters result in: 1) obstruction and dilatation of the submaxillary gland ducts (7); 2) elevation of concentrations of Na' , Ca2', protein, and carbohydrates in saliva (8); 3) presence of a ciliotoxic factor in the saliva (8); 4) elevation of concentrations of a specific glycoprotein (1 5) as well as total protein, lipid, and carbohydrate content (9) in lung lavage fluid; and 5) reduction in volume, flow rate, bicarbonate concentration, and chloride concentration of pancreatic secretions ( 12) .
Isoproterenol is a sympathomimetic amine which has been shown to induce: 1) enlargement of parotid and submaxillary glands; 2) functional changes in parotid glands, such as increased Na' concentration in parotid saliva, increased viscosity of parotid saliva, and altered macromolecular composition by acrylamide gel electrophoresis; 3) the presence of ciliary dyskinetic activity in serum (6); 4) hyperplasia of goblet cells in the trachea and at all levels of the bronchial tree; 5) hypertrophy of tracheal submucosal glands (14) , and 6) increased lipid content in lavage fluid (10) . These responses to reserpine and isoproterenol representative of CF led to this study, the objective of which was to determine the pulmonary function responses in these chemically induced models of CF.
MATERIALS A N D METHODS
Male Sprague-Dawley rats were obtained from Charles River Breading Laboratories (Kingsport, NY) from a colony documented to be free of respiratory pathogens such as Mycoplasma pulmonis and Sendai virus. The rats were housed at the University of Florida Health Center Animal Resources Department in the quarantine area away from other animals for the duration of the study. The rats were fed commercial rat food and given water ad libitum. The rats were given six daily injections of RES (0.5 mg/kg/day, n = 6) similar to the regimen described by Martinez et al. IS0 (7), (25 mg/kg/day, n = 9) as described by Sturgess and Reid (14) , or equivolume saline as controls (ConR, n = 6; ConI, n = 9; 1.0 ml/kg/day). No injections were made on day 7, and on day 8 the pulmonary function of each rat was measured.
The pulmonary function measurements were made by methods described previously from this laboratory (4). The tests included functional residual capacity (FRC, ml), FRC per kg body weight (sFRC, ml/kg), airway resistance (Kw, cm H20/ml/ sec), specific airway conductance (sG,, ml/sec/cmH20/sec/ml), phase difference between flow rate at the nose and mean alveolar pressure (PD, degrees), tidal volume (VT, ml), and frequency of breathing (f, Hz).
A DuBois-type plethysmograph system (in which the animal breathed internal air only) was used to determine the Kw and sGaw of the anesthetized, spontaneously nose-breathing rats. This system has been described previously for use with rats of similar size (4). Briefly, the 1.1-liter water-jacketed plethysmograph was constructed from a 6-cm i.d. x 39 cm long x 0.3 cm wall thickness Plexiglas tubing. A 10-tom pressure transducer (Barocel, Model 1 173, Datametrics, Inc., Wilmington, MA 0 1887) was connected to the plethysmograph, which detected the change in pressure resulting from change in volume (V,, 0.026 ml/torr) due to compression or expansion of intrathoracic gas during the respiratory cycle. Within the plethysmograph, a pneumotachometer (No. 0000 Fleisch, Dynascience, Blue Bell, PA) connected to an MP45; k50 cm H20 pressure transducer (Validyne Engineering, Northridge, CA 91324) and an HP8805B amplifier (Hewlett-Packard, Waltham, MA 02 154) was used to measure flow rate at the nose (V., ml/sec). The frequency response of all channels of the system was flat through at least 7 Hz. The animal breathed through the pneumotachometer via a silicone rubber facemask molded to the shape of the face. A seal between the face and mask was facilitated by depilitating the face with Neet (Whitehall Laboratories, Inc., New York) and forming a gasket with a dental adhesive (Super-Poligrip, Dentco, Inc., Jersey City, NJ). The dead space volume of the facemask-pnuemotachometer-transducer system was 5.1 ml, as determined by the mehtod of Palecek (19) . By appropriate valving, the same MP45 transducer was used to measure airway opening pressure (Pao, cm H20). The Pao was measured during respiratory efforts after occluding the airway opening during an expiratory pause to determine thoracic gas volume as an index of FRC. Measurement of Kw requires that the animal breathe gas at or near conditions of alveolar temperature and H 2 0 saturation. These conditions were established throughout the plethysmograph by flushing with warmed humidified air. Exchange of respiratory gases resulted in a net decrease in volume in the closed plethysrnograph.
Oxygen was therefore metered into the box at a constant rate adjusted to the net gas exchange rate of each rat to compensate for the volume decrease. At testing, each anesthetized animal was placed prone in the plethysmograph with the face sealed in the face mask. The system was flushed with warmed humidified air for approximately 6 min. The flushing was stopped, the plethysmograph was closed, and the oxygen flow rate was adjusted to maintain box pressure at atmospheric. During spontaneous nose-breathing, three V, versus V, tracings were displayed on a storage oscilloscope (Model 5103N, Tektronix, Beaverton, OR 97005) and photographed (Fig. 1) . Each V, versus V . tracing represents at least two breaths, after which the oscilloscope beam was turned off and repositioned to make the next tracing of at least two breaths. The "figure-eight" V, versus V, tracings are analogous to the pressure versus flow curves described by Jaeger and Bouhuys quadrant), expansion of intrathoracic gas increases with increasing lung volume and flow rate and decreases at end inspiration as flow rate decreases to zero; then during expiration (third quadrant), compression of the.gas occurs and during the end expiratory pause the V, versus V, tracing returns to its origin. In normal animals, slight differences of the temperature and humidity of inspired gas from those of alveolar gas may result in a net expansion of intrathoracic gas at end inspiration. Measurements were made at a rectal temperature of 38.O"C with the air temperature at 38.25"C. Measurements by this temperature regimen resulted in a net expansion of gas at end inspiration. Net expansion or compression of intrathoracic gas also occurs when V, is out of phase with V, as a result of uneven distribution of ventilation (1, 4) . The angle between the V, = 0 on the x axis, a line connnecting peak inspiratory V, and peak expiratory V. of each V, -V, tracing, was measured with a protractor mounted on the oscilloscope to determine their respective slopes. Using the slope of the V, versus V, curve and Boyle's law to estimate alveolar pressure from V,, the total airway resistance (k,) was computed (4). Three independent V, versus Pao tracings ( (4) . The average of the three determinations was used as the data for each animal. Specific FRC (sFRC) was computed as FRC/body weight. Specific airway conductance (sG.,) was computed as (l/kW)/FRC.
The phase difference (PD) between V. and mean alveolar gas pressure (derived by Boyle's law from V,) is based on the concept of asynchronous filling and emptying of lung compartments (1 I) and is an index of uneven distribution of ventilation (1). The PD was calculated from the same V, versus V, tracing used for k, determination (Fig. 16) as the arcsine of the ratio at V,, at V, = 0, to the maximal V, during a breathing cycle (I). The tidal volume (VT, ml; determined by integration of the V, with a HP88 16A respiratory analyzer) was recorded against time on the storage oscilloscope and photographed (Fig. 1 a) . From this tracing, the V, and frequency of breathing (f, Hz) were measured. Data are reported as the mean ? standard error and were analyzed by the analysis of variance and Student's t test at the p < 0.05 level of significance ( 13) .
RESULTS
Reserpine. The results of this study are shown in Table I . These results show that the body weight in kilograms was significantly less in the RES rats compared to that of the ConR rats. The FRC of the RES rats was not different from that of the ConR rats, but, because of the depressed body weight, the sFRC was increased in the RES rats. The Raw of the RES rats was not Table 1 . Pulmonary function measurements of control, reserpine, and isoproterenol-treated rats different from ConR value. However, when normalized for lung volume at FRC, the total sG, was significantly increased, suggesting an enlargement of the caliber of central airways. The PD between flow rate and mean alveolar pressure of the RES rats was significantly increased, indicating uneven distribution of ventilation. The f of the RES rats was not different from that of the ConR rats; whereas the VT was significantly lower in the RES rats.
Isoproterenol. Similar results were obtained in the IS0 rats with decreased body weight but no change in FRC or sFRC as compared to the ConI rats values. Likewise, no differences were observed in R , , , or sG,,. However, the PD was greater in the IS0 rats than in the ConI rats at the same f, but with reduced VT.
Pulmonary function values for the ConR and ConI rats were similar to those reported previously for control rats (4) .
DISCUSSION
The pulmonary function in these two proposed models of cystic fibrosis using reserpine-treated rats and isoproterenoltreated rats was affected primarily by uneven distribution of ventilation. The methodology for studying distribution of ventilation was based on the concept of distribution of time constants in the peripheral airway-alveolar compartments (1 I). The two principal determinants of the relationship of flow rate to mean alveolar pressure are the resistance of the peripheral airways and compliance of the alveoli. In this study, since the FRC of the treated rats was not different from that of the control rats, there is no indication that the pulmonary compliance was affected by the reserpine or the isoproterenol treatment. Subsequently, the determinant component for the observed differences in distribution of ventilation is expected to be inequality ofthe peripheral airways resistance.
Changes in peripheral resistances would be expected from the morphologic alteration of the bronchiolar epithelial cells and glands due to treatment with isoproterenol as described by Sturgess and Reid (14) . While no morphological alteration to the airway epithelium of reserpine-treated rats has been previously reported, the data from this study indicating uneven distribution of the time constants would suggest that such alterations would result from reserpine treatment.
The magnitude of the phase difference has been demonstrated mathematically to be frequencydependent (1,4). However, the frequency of breathing of the treated rats was the same as that of the control rats. The higher phase difference of the treated rats, --therefore, would reflect an uneven distribution of time constants without frequency interference. It has also been demonstrated that the magnitude of the phase difference at a given frequency is more sensitive to inequality of peripheral resistances than to inequality of peripheral compliances (1). This is consistent with the physiologic interpretations that we have made in this study.
The reduced tidal volume in both models is consistent with penduluft or movement of some gas between alveolar compartments as the alveolar pressures equilibrate between breaths (1 1). Another interpretation of the reduced tidal volume could be hypoventilation in the anesthetized rats. However, since sodium pentobarbital was the anesthetic used, an increased responsiveness would be expected to cause hypoventilation by decreased frequency. But since frequency of breathing was not affected, penduluft appears to be the more logical mechanism for the reduced tidal volume.
In patients with cystic fibrosis, one of the earliest indications of pulmonary function impairment is an abnormality in distribution of ventilation resulting in increased alveolar-arterial oxygen differences ( 1 7). This is consistent with the concept that the initial pulmonary lesion in cystic fibrosis is in the peripheral airways (5) . PD measurements made in the two animal models of this study similarly indicate peripheral airways involvement resulting in inequality of time constants which causes uneven distribution of ventilation. Based on these interpretations, the results of this study provide additional evidence that the reser-pine-treated rat and the isoproterenol-treated rat may be appropriate models for laboratory study of the pulmonary involvement of cystic fibrosis, particularly of the early pulmonary lesions which affect the peripheral airways.
While these pharmacologic manipulations result in glandular function abnormalities in rats similar to those observed in patients with CF, it is clear that the disease cystic fibrosis is not induced in these animals. Rather, two model systems are induced with particular physiologic or histologic characteristics similar to CF. By studying these models, a better understanding of the mechanisms of cellular function leading to the physiologic or morphologic abnormalities may be gained.
Since abnormalities in peripheral airway function in CF patients leads to pregressive deterioration of pulmonary sufficiency, it is important to understand the relationship of structural changes to progressive changes in pulmonary function. Use of these models with the pulmonary function measurement procedures described in this report in conjunction with histologic analysis of airways during progression or regression of the induced alterations would facilitate correlation of structure-function relationships. A better understanding of the extent of airway alteration required to affect pulmonary function could be gained from such studies. Knowledge gained from studies with these model systems may lead to an improved interpretation of clinical pulmonary function findings in CF patients or at least a better appreciation for the sensitivity of the measurement procedures.
Moreover, this study showed that phase difference between air flow rate and mean alveolar pressure was sensitive to peripheral airways alterations when tests for large airways function (R,) and resting lung volume (FRC) showed no abnormalities. The PD as an index of distribution of ventilation may, therefore, be useful in evaluation of the pulmonary status of CF patients. In view of the minimal cooperation required by the subject, this methodology adapted to children could yield valuable information when other less sensitive or more patient cooperation dependent methods are not practical.
